Financials IM Cannabis Corp. Nasdaq

Equities

IMCC

CA44969Q3070

Pharmaceuticals

Market Closed - Nasdaq 16:00:00 2024-05-22 EDT 5-day change 1st Jan Change
0.626 USD -1.40% Intraday chart for IM Cannabis Corp. -11.84% +75.35%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 49.55 399 287.7 9.84 6.161 10.05 -
Enterprise Value (EV) 1 49.55 399 287.7 9.84 6.161 10.05 10.05
P/E ratio - - - - - - -
Yield - - - - - - -
Capitalization / Revenue 5.46 x 25.1 x 5.3 x 0.18 x 0.13 x 0.19 x 0.16 x
EV / Revenue 5.46 x 25.1 x 5.3 x 0.18 x 0.13 x 0.19 x 0.16 x
EV / EBITDA -27.3 x -71.3 x -13.1 x -0.86 x -0.77 x -2.31 x -124 x
EV / FCF - - -7,387,347 x -692,887 x - - -
FCF Yield - - -0% -0% - - -
Price to Book - - - - - - -
Nbr of stocks (in thousands) 3,644 3,974 6,818 7,570 13,394 13,394 -
Reference price 2 13.60 100.4 42.20 1.300 0.4600 0.7500 0.7500
Announcement Date 4/20/20 4/23/21 3/31/22 3/29/23 3/28/24 - -
1CAD in Million2
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net sales 1 9.074 15.89 54.3 54.34 48.8 53.35 63.58
EBITDA 1 -1.814 -5.592 -22.03 -11.49 -7.97 -4.348 -0.0808
EBIT 1 - - -38.39 -30.79 -12.79 -11.9 -5.355
Operating Margin - - -70.7% -56.67% -26.21% -22.31% -8.42%
Earnings before Tax (EBT) 1 - - -18.01 -26.06 -9.457 -13.93 -7.329
Net income 1 - - -18.52 -188.9 -9.498 -13.7 -6.002
Net margin - - -34.1% -347.64% -19.46% -25.67% -9.44%
EPS - - - - - - -
Free Cash Flow - - -38.95 -14.2 - - -
FCF margin - - -71.73% -26.14% - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 4/20/20 4/23/21 3/31/22 3/29/23 3/28/24 - -
1CAD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 20.03 23.57 23.82 14.17 14.46 13.17 13.21 12.37 10.7 12.06 13.16 13.83 14.33 14 15.2
EBITDA 1 -8.278 -4.504 -4.624 -3.666 -1.884 -1.284 -0.499 -1.293 -4.251 -4.881 -0.9805 -0.7278 -0.4626 -0.3 -0.1
EBIT 1 -11.72 -11.55 -11.64 -5.526 -10.71 2.973 -1.752 -2.259 -5.165 -5.63 -2.262 -2.134 -1.944 -1.7 -1.5
Operating Margin -58.53% -49% -48.89% -39% -74.05% 22.57% -13.27% -18.26% -48.28% -46.67% -17.19% -15.43% -13.56% -12.14% -9.87%
Earnings before Tax (EBT) 1 -12.16 -10.99 -20.16 -4.328 -9.76 0.028 -3.866 -2.011 -2.699 -6.131 -2.755 -2.627 -2.437 -2.2 -2
Net income 1 -12.49 -9.452 -18.98 -127.8 -33.03 0.309 -3.459 -2.15 -3.289 -5.623 -2.69 -2.568 -2.38 -2.2 -2
Net margin -62.35% -40.1% -79.67% -901.82% -228.39% 2.35% -26.19% -17.38% -30.74% -46.61% -20.44% -18.57% -16.61% -15.71% -13.16%
EPS - - - - - - - - - - - - - - -
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 3/31/22 5/12/22 8/15/22 11/14/22 3/29/23 5/15/23 8/14/23 11/13/23 3/28/24 5/8/24 - - - - -
1CAD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - - -39 -14.2 - - -
ROE (net income / shareholders' equity) - - - - - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share - - - - - - -
Cash Flow per Share - - - - - - -
Capex - 2.62 4.58 - - - -
Capex / Sales - 16.49% 8.43% - - - -
Announcement Date 4/20/20 4/23/21 3/31/22 3/29/23 3/28/24 - -
1CAD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.75 CAD
Average target price
3.45 CAD
Spread / Average Target
+360.00%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. IMCC Stock
  4. IMCC Stock
  5. Financials IM Cannabis Corp.